Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study

NCT04550481 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Nonalcoholic Steatohepatitis

Interventions

PROCEDURE: Biospecimen Collection
DRUG: Lisinopril
PROCEDURE: Liver Ultrasonographic Elastography
PROCEDURE: Magnetic Resonance Elastography
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Proton Density Fat Fraction
OTHER: Questionnaire Administration

Sponsor

Northwestern University

Collaborators

[object Object]